Ozempic delivers major weight loss in adults over 65, study finds

A new analysis of the STEP trials suggests that semaglutide, the active ingredient in the popular weight loss and diabetes drugs Wegovy and Ozempic, remains both effective and generally safe for adults over age 65 with obesity. Researchers found…

Continue Reading

News Source: www.sciencedaily.com